Skip to main content
All lobbying filings

AMERICAN COLLEGE OF CLINICAL PHARMACY

Lobbying for AMERICAN COLLEGE OF CLINICAL PHARMACY

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $144,981.00 expenses · posted Apr 6, 2026

Official filing document

 Lobbying activity 5
Pharmacy

Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs.

Medicare/Medicaid

Promote enhanced quality, structure and information dissemination concerning medication therapy management services (MTMS) under Medicare Part D.

Health Issues

Promote greater medication safety and more appropriate medication use through more active involvement of pharmacists in patient care.

Education

Seek restoration of Medicare funding for specialized residency training under Medicare prospective payment rules. Seek pharmacist participation in National Health Service Corps (NHSC) loan repayment programs. Support development of inter-professional health education programs by working with Congress to make programs authorized under Title VII of the Public Health Service Act a significant aspect of comprehensive health professions education.

Medical/Disease Research/Clinical Labs

Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem